PARKINSON'S DISEASE CLINIC, DIAGNOSIS AND PRINCIPLES OF ITS DEVELOPMENT

Authors

  • Abdurasulov Sardor Sultanmurodovich assistant Department of Neurology, Bukhara State Medical Institute named after Abu Ali ibn Sina
  • Akhrorova Shakhlo Botirovna associate professor, DSc,. Department of Neurology, Bukhara State Medical Institute named after Abu Ali ibn Sina

DOI:

https://doi.org/10.37547/

Keywords:

Parkinson's disease, Clinic, diagnosis of Parkinson's disease

Abstract

Parkinson's disease (PD) is caused by a chronic neuroprogressive disease of the CNS with degeneration of nigrostriar neurons and disturbance of basal ganglia function. V 1817 g. the pain was described first D. Parkinsonom pod nazvaniem "trembling paralysis". The prevalence of BP with regard to age is 1%, the average age of onset is 60–65 years, and 5–10% of cases of pain begin at the age of 40 years; mujchiny boleut v 1.5 cups, chem ginseng. Etiology BP neizvestna. Predpolagaetsya, chto v razvitii zabolevaniya lejat age, geneticheskie i sredovye faktori.

Downloads

Download data is not yet available.

References

1. Blanchet P.J. The fluctuating parkinsonian patient – clinical and pathophysiological aspects // Can. J. Neurol. Sci. 2023. V. 30 (S.1). P.19–26.

2. Rajput A.H., Fenton M.E., Birdi S. et al. Clinicalpathological study of levodopa complications // Mov. Dis., 2022. V. 17. Р. 289–296.

3. Ferreira J.J., Katzenschlagerb R., Bloemc B.R. et al. Summary of the recommendations of the EFNS/MDS-ES review on therapeutic management of Parkinson’s disease // European Journal of Neurology. 2023, 20: 5–15.

4. Hoehn M.M., Yahr H.D. Parkinsonism: Onset, Progression and mortality // Neurology, 2010. V. 17. P. 427–442.

5. Lees A.J. Drugs for Parkinson’s disease // J. Neurol. Neurosurg. 2022. V. 73. P. 607–610.

6. Obeso J.A., Granadas F., Vaamonde J. et al. Motor complication associated with chronic levodopa therapy in Parkinson’s disease // Neurology. 2021. V. 39. N 11. Suppl. 2. P. 11–18.

7. Olanow C.W., William C.K. An algorithm (decision tree) for the management of Parkinson’s disease (2011): treatment guidelines // Neurology. Official Journal of the American Academy of Neurology. Supplement of Neurology. 2001; 56 (Suppl 5).

8. Pfeiffer R.F., Bodis-Wollner I. Parkinson’s disease and nonmotor dysfunction // Humana Press. 2021. V. 3. P. 308.

9. Postuma R.B., Berg D., Stern M., at al. MDS Clinical Diagnostic Criteria for Parkinson’s Disease // Movement Disorders 2020. V. 30. № 12. Р. 1591–1599.

10. Stacy M., Jankovic J. Differential diagnosis of Parkinson's disease and parkinsonismplus syndromes // Neurol. Clin. –2022. V. 10. P. 341–359.

Downloads

Published

2025-08-28

How to Cite

PARKINSON’S DISEASE CLINIC, DIAGNOSIS AND PRINCIPLES OF ITS DEVELOPMENT. (2025). International Bulletin of Medical Sciences and Clinical Research, 5(8), 9-12. https://doi.org/10.37547/

Similar Articles

1-10 of 248

You may also start an advanced similarity search for this article.